International Patent: USE OF KDM5B INHIBITOR IN PREPARATION OF DRUG FOR TREATING EBV-RELATED EPITHELIAL TUMORS

GENEVA, June 26 -- SUN YAT-SEN UNIVERSITY CANCER CENTER (THE AFFILIATED CANCER HOSPITAL OF SUN YAT-SEN UNIVERSITY, SUN YAT-SEN UNIVERSITY CANCER INSTITUTE) filed a patent application (CN2024/138026) for “USE OF KDM5B INHIBITOR IN PREPARATION OF DRUG FOR TREATING EBV-RELATED EPITHELIAL TUMORS”. With publication no. WO/2026/118087, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 45/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....